Co-injection of G93A-SOD1 RNA (50 ng/μl) with igf-I RNA (200 ng/μl) demonstrates that these defects are attenuated by IGF-I upregulation (Figure 1C), a known neuroprotective strategy in ALS model systems [41]. Here, IGF1 is linked to amyotrophic lateral sclerosis.